These findings indicate that SIRT-1 is a direct target of miR-204 and manipulating vascular miR-204 expression during obesity can potentially be a great therapeutic target against obesity-induced endothelial dysfunction. The gene discussed is SIRT1; the disease is obesity due to melanocortin 4 receptor deficiency.